Drug shortage
Doxycycline Hyclate Tablet · Mylan Pharmaceuticals Inc., a Viatris Company
FDA drug shortage · To Be Discontinued · updated Jan 12, 2026
Key facts
| Generic name | Doxycycline Hyclate Tablet |
|---|---|
| Company | Mylan Pharmaceuticals Inc., a Viatris Company |
| Presentation | Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Anti-Infective |
| Package NDCs | 0378-0167-02 |
| First posted | Jan 12, 2026 |
| Last updated | Jan 12, 2026 |
| Discontinued | Jan 12, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: